CD8A and neoplasm: Subsequently, the authors validated the ability of this nano system to stimulate CD8 T-cell immune responses by delivering ovalbumin (OVA) and human papillomavirus 16 (HPV16) mRNA, achieving high anti-tumor efficacy.